Skip to menu Skip to content Skip to footer

2008

Conference Publication

Genotyping and expression studies of 7p22 candidate genes in familial hyperaldosteronism type II

Jeske, Y.W., So, A., Kelemen, L., Sukor, N., Willys, C., Gordon, R.D., Duffy, D. and Stowasser, M. (2008). Genotyping and expression studies of 7p22 candidate genes in familial hyperaldosteronism type II. 29th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Adelaide, Australia, 5-8 December 2007. United States: Lippincott Williams & Wilkins. doi: 10.1161/HYPERTENSIONAHA.108.009996

Genotyping and expression studies of 7p22 candidate genes in familial hyperaldosteronism type II

2008

Conference Publication

Semi-automated analysis of aldosterone by liquid chromatography-tandem mass spectrometry: the new gold standard

Taylor, P. J., Cooper, D. P., Gordon, R. D. and Stowasser, M. (2008). Semi-automated analysis of aldosterone by liquid chromatography-tandem mass spectrometry: the new gold standard. 29th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Adelaide, Australia, 5-8 December 2007. United States: Lippincott Williams & Wilkins. doi: 10.1161/HYPERTENSIONAHA.108.009996

Semi-automated analysis of aldosterone by liquid chromatography-tandem mass spectrometry: the new gold standard

2008

Conference Publication

Familial hyperaldosteronism type II - evidence for linkage at chromosome 7p22 in families from Australia, South America and Italy

Sukor, N., Stowasser, M., So, A., Duffy, D., Kelemen, L., Jeske, Y., Mulatero, P. and Gordon, R.D. (2008). Familial hyperaldosteronism type II - evidence for linkage at chromosome 7p22 in families from Australia, South America and Italy. 29th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Adelaide, Australia, 5-8 December 2007. United States: Lippincott Williams & Wilkins. doi: 10.1161/HYPERTENSIONAHA.108.009996

Familial hyperaldosteronism type II - evidence for linkage at chromosome 7p22 in families from Australia, South America and Italy

2008

Conference Publication

Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II

Jeske, Y., So, A., Kelemen, L, Sukor, N., Willys, C., Bulmer, B. J., Gordon, R. D., Duffy, D. and Stowasser, M. (2008). Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. IVth Franco-Australian Meeting on Hypertension, Northern Territory, Australia, September 2007. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1681.2008.04882.x

Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II

2008

Conference Publication

Measurement of aldosterone (aldo) by semi-automated liquid chromatography-tandem mass spectrometry (LC-MS/MS)

Taylor, P., Cooper, D., Gordon, R. and Stowasser, M. (2008). Measurement of aldosterone (aldo) by semi-automated liquid chromatography-tandem mass spectrometry (LC-MS/MS). 18th Scientific Meeting of the European Society of Hypertension/22nd Scientific Meeting of the International Society of Hypertension, Berlin, Germany, 14-19 June 2008. United States: Lippincott Williams & Wilkins, Ltd..

Measurement of aldosterone (aldo) by semi-automated liquid chromatography-tandem mass spectrometry (LC-MS/MS)

2007

Conference Publication

Can liquid chromatography-tandem mass spectrometry solve the problem of aldosterone measurement?

Taylor, P., Carlton, L., Franklin, M., Cooper, D., Gordon, R.D. and Stowasser, M. (2007). Can liquid chromatography-tandem mass spectrometry solve the problem of aldosterone measurement?. 28th annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, 7-8 December, 2006. Philadelphia: Lippincott Williams & Wilkins. doi: 10.1161/HYPERTENSIONAHA.107.009421

Can liquid chromatography-tandem mass spectrometry solve the problem of aldosterone measurement?

2007

Conference Publication

In hereditary hyperkalemic hypertension, genetic heterogeneity, salt intake and medications affet phenotype and delay diagnosis. Will genetic testing resolve this?

Ku, Y., Stowasser, M., O'Shaughnessy, K. and Gordon, R. D. (2007). In hereditary hyperkalemic hypertension, genetic heterogeneity, salt intake and medications affet phenotype and delay diagnosis. Will genetic testing resolve this?. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, 7-8 December 2006. Philadelphia, USA: Lippincott Williams & Wilkins.

In hereditary hyperkalemic hypertension, genetic heterogeneity, salt intake and medications affet phenotype and delay diagnosis. Will genetic testing resolve this?

2007

Conference Publication

Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous samplings

Stowasser, M., Ward, G., Leggett, D., Cowley, D. and Gordon, R. (2007). Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous samplings. 17th European Meeting on Hypertension, Milan, Italy, 15th - 19th June, 2007. Philadelphia, USA: Lippincott Williams and Wilkins.

Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous samplings

2007

Conference Publication

Examination of candidate genes at chromosome 7p22 in familial hyperaldosteronism type II

Jeske, YW, So, A, Kelemen, L, Bulmer, B, Gordon, RD, Duffy, D and Stowasser, M (2007). Examination of candidate genes at chromosome 7p22 in familial hyperaldosteronism type II. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, Australia, 7-8 December 2006. Baltimore, MD: Lippincott Williams & Wilkins for the American Heart Association. doi: 10.1161/HYPERTENSIONAHA.107.009421

Examination of candidate genes at chromosome 7p22 in familial hyperaldosteronism type II

2007

Conference Publication

Cardiovascular effects of unilateral adrenalectomy are superior to those of aldosterone antagonist treatment in primary aldosteronism

Stowasser, Michael, Cowley, Diane, Gordon, Richard, Sharman, James and Marwick, Thomas (2007). Cardiovascular effects of unilateral adrenalectomy are superior to those of aldosterone antagonist treatment in primary aldosteronism. 2007 Scientific Sessions of the American Heart Association, Orlando, Florida, 3 - 7 November, 2007. Baltimore, MD.: Lippincott, Williams & Wilkins for the American Heart Association.

Cardiovascular effects of unilateral adrenalectomy are superior to those of aldosterone antagonist treatment in primary aldosteronism

2007

Conference Publication

Adrenal cortico-medullary interactions: pheochromocytoma-associated cortical hyperplasia and benign neoplasia

Sukor, N., Stowasser, M., Rutherford, J., Nicol, D. L., Cohn, D. and Gordon, R. D. (2007). Adrenal cortico-medullary interactions: pheochromocytoma-associated cortical hyperplasia and benign neoplasia. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, 7-8 December 2006. USA: American Heart Association. doi: 10.1161/HYPERTENSIONAHA.107.009421

Adrenal cortico-medullary interactions: pheochromocytoma-associated cortical hyperplasia and benign neoplasia

2007

Conference Publication

Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous sampling

Stowasser, M., Ward, G., Leggett, D., Cowley, D. and Gordon, R. (2007). Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous sampling. 17th European Meeting on Hypertension, Milan, Italy, 15-19 June 2007. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Rapid cortisol measurement aids in real-time confirmation of successful cannulation during adrenal venous sampling

2007

Conference Publication

Identification of individuals most likely to benefit from non-invasive central blood pressure monitoring

Sharman, J. E., Stowasser, M., Holland, D. J. and Marwick, T. H. (2007). Identification of individuals most likely to benefit from non-invasive central blood pressure monitoring. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Australia, 2006. Philadelphia, PA, U.S.A.: Lippincott Williams & Wilkins. doi: 10.1161/HYPERTENSIONAHA.107.009421

Identification of individuals most likely to benefit from non-invasive central blood pressure monitoring

2007

Conference Publication

Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22

So, A, Jeske, Y., Gordon, R. D., Duffy, D., Kelemen, L., Bulmer, B. and Stowasser, M. (2007). Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, Australia, 7-8 December 2006. Baltimore, USA: Lippincott Williams & Wilkins for the American Heart Association. doi: 10.1161/HYPERTENSIONAHA.107.009421

Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22

2006

Conference Publication

The expanding role of aldosterone excess in cardiovascular disease

Stowasser, M., Sharman, J., Marwick, T. and Gordon, R. (2006). The expanding role of aldosterone excess in cardiovascular disease. 21sth Scientific Meeting of the International Society of Hypertension, 5th Asian Pacific Congress of Hypertension and 29th Annual Scientific Meeting of the Japanese Society of Hypertension, Fukuoka, Japan, 15-19 October 2006. United Kingdom: Lippincott Williams & Wilkins, Ltd..

The expanding role of aldosterone excess in cardiovascular disease

2006

Conference Publication

Further evidence of linkage at 7p22 with familial hyperaldosteronism type II and exclusion of genetic defects in the RBAK coding regions

So, A., Jeske, Y., Gordon, R. D., Duffy, D. L., Bulmer, B. J. and Stowasser, M. (2006). Further evidence of linkage at 7p22 with familial hyperaldosteronism type II and exclusion of genetic defects in the RBAK coding regions. 27th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Melbourne, Australia, 7-9 December, 2006. Oxford, UK: Blackwell. doi: 10.1111/j.1440-1681.2006.04428.x

Further evidence of linkage at 7p22 with familial hyperaldosteronism type II and exclusion of genetic defects in the RBAK coding regions

2006

Conference Publication

No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II

So, A., Jeske, Y., Gordon, R. D., Duffy, D., Kelemen, L. and Stowasser, M. (2006). No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15 to 19 October 2006. Japan: International Society of Hypertension.

No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II

2006

Conference Publication

Prevalence of primary aldosteronism among Chinese hypertensive patients

Gong, Y., Zhu, D., Zhang,, Chen, S. L., Chu, S.X., Zhang, L.H., Stowasser, M. and Gordon, R. D. (2006). Prevalence of primary aldosteronism among Chinese hypertensive patients. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15th to 19th October, 2006. Japan: International Society of Hypertension.

Prevalence of primary aldosteronism among Chinese hypertensive patients

2006

Conference Publication

Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism

Kostner, K., Liu, Y., Cowley, D. and Stowasser, M. (2006). Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism. ISA 2006: XIV International Symposium on Atherosclerosis, Rome, Italy, 18-22 June 2006. E. Park, Shannon, Co. Clare, Ireland: Elsevier Ireland. doi: 10.1016/S1567-5688(06)81883-0

Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism

2005

Conference Publication

Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred

Stowasser, M, Elphinstone, M, So, A, Jeske, Y and Gordon, R (2005). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. 26th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, Sydney Australia, Nov 24-26, 2004. OXFORD: BLACKWELL PUBLISHING.

Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred